Drugs / Invossa K Inj.
last change Mar 2020 re-read 3 minutes ago

Invossa K Inj.

Developed for
osteoarthritis
Investigated by
Kolon Life Science

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03383471 Feb 2018 → Dec 2019 osteoarthritis Kolon Life Science Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Invossa K Inj. ClinicalTrials.gov intervention name — accepted as the source's own label NCT03383471 ↗